The Journal of Medical Microbiology, Vol 48, Issue 4 363-366, Copyright © 1999 by Society for General Microbiology

JOURNAL ARTICLE

Experimental pathogenicity of four opportunist Fusarium species in a murine model

E. Mayayo, I. Pujol and J. Guarro
Servei Patologia, Hospital Universitari de Tarragona Joan XXIII, Spain.

A murine model with immunocompetent animals was used in a comparative study of experimental pathogenicity of 13 isolates belonging to the four most frequent pathogenic species of Fusarium in man (F. solani, F. oxysporum, F. verticillioides and F. proliferatum). Inocula of 5 x 10(6) conidia/mouse of each isolate of Fusarium were injected into a lateral vein of the tail of the mice to produce a systemic infection. F. solani was the most virulent species; the five strains of this species assayed caused the death of all the animals tested in <19 days. The other species of Fusarium were not virulent in this model. The organs mainly affected by F. solani were the kidneys and the heart. These findings correlate with the clinical evidence and demonstrate that there is a high risk associated with infection by F. solani, especially for immunocompromised patients.

This article has been cited by other articles:

				Z. U. Khan, S. Ahmad, and A. M. Theyyathel Diagnostic value of DNA and (1->3)- -D-glucan detection in serum and bronchoalveolar lavage of mice experimentally infected with Fusarium oxysporum J. Med. Microbiol., January 1, 2008; 57(1): 36 - 42. [Abstract] [Full Text] [PDF]

				M. Nucci and E. Anaissie Fusarium Infections in Immunocompromised Patients Clin. Microbiol. Rev., October 1, 2007; 20(4): 695 - 704. [Abstract] [Full Text] [PDF]

				M. Azor, J. Gene, J. Cano, and J. Guarro Universal In Vitro Antifungal Resistance of Genetic Clades of the Fusarium solani Species Complex Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1500 - 1503. [Abstract] [Full Text] [PDF]

				B. Spellberg, J. Schwartz, Y. Fu, V. Avanesian, J. Adler-Moore, J. E. Edwards Jr, and A. S. Ibrahim Comparison of antifungal treatments for murine fusariosis J. Antimicrob. Chemother., November 1, 2006; 58(5): 973 - 979. [Abstract] [Full Text] [PDF]

				Y.-s. Ha, S. F. Covert, and M. Momany FsFKS1, the 1,3-{beta}-Glucan Synthase from the Caspofungin-Resistant Fungus Fusarium solani. Eukaryot. Cell, July 1, 2006; 5(7): 1036 - 1042. [Abstract] [Full Text] [PDF]

				C. Ferrer, J. Alio, A. Rodriguez, M. Andreu, and F. Colom Endophthalmitis Caused by Fusarium proliferatum J. Clin. Microbiol., October 1, 2005; 43(10): 5372 - 5375. [Abstract] [Full Text] [PDF]

				R. Nir-Paz, J. Strahilevitz, M. Shapiro, N. Keller, A. Goldschmied-Reouven, O. Yarden, C. Block, and I. Polacheck Clinical and Epidemiological Aspects of Infections Caused by Fusarium Species: a Collaborative Study from Israel J. Clin. Microbiol., August 1, 2004; 42(8): 3456 - 3461. [Abstract] [Full Text] [PDF]

				M. S. Lionakis, R. E. Lewis, G. Samonis, and D. P. Kontoyiannis Pentamidine Is Active In Vitro against Fusarium Species Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3252 - 3259. [Abstract] [Full Text] [PDF]

				J. Guarro, M. Nucci, T. Akiti, and J. Gené Mixed Infection Caused by Two Species of Fusarium in a Human Immunodeficiency Virus-Positive Patient J. Clin. Microbiol., September 1, 2000; 38(9): 3460 - 3462. [Abstract] [Full Text]

				J. Guarro, M. Nucci, T. Akiti, J. Gené, M. D. G. C. Barreiro, and R. T. Gonçalves Fungemia Due to Fusarium sacchari in an Immunosuppressed Patient J. Clin. Microbiol., January 1, 2000; 38(1): 419 - 421. [Abstract] [Full Text]